Barclays Sticks to Their Hold Rating for Molina Healthcare (MOH)


Barclays analyst Steven Valiquette maintained a Hold rating on Molina Healthcare (MOH) yesterday and set a price target of $135. The company’s shares closed yesterday at $124.72.

According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 6.2% and a 51.2% success rate. Valiquette covers the Services sector, focusing on stocks such as Patterson Companies Inc, WellCare Health Plans, and Community Health.

Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $159.

See today’s analyst top recommended stocks >>

Based on Molina Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.7 billion and net profit of $197 million. In comparison, last year the company earned revenue of $5.03 billion and had a GAAP net loss of $97 million.

Based on the recent corporate insider activity of 105 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Molina Medicaid Solutions segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico, and includes our direct delivery business.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts